Hypoxic Ischemic Encephalopathy: Why is it important?
Executive Biography:
Dr. Shoo Lee is a neonatologist and health economist. He is a Professor of Paediatrics, Obstetrics and Gynaecology, and Head of the Division of Neonatology at the University of Toronto; Paediatrician-in-Chief and Director of the Maternal-Infant Care (MICare) Research Centre at Mt. Sinai Hospital; Chief of the Department of Newborn and Developmental Paediatrics at Sunnybrook Health Sciences Centre; and The Women’s Auxiliary Chair in Neonatology and Head of the Division of Neonatology at the Hospital for Sick Children.
He received his medical degree from the University of Singapore, completed paediatric training at the Janeway Children's Hospital in Newfoundland and neonatal fellowship training at Boston’s Children’s Hospital, and received his PhD in Health Policy (Economics) from Harvard University.
He established the Canadian Neonatal NetworkTM and the International Neonatal Collaboration to foster collaborative research and leads the CIHR Team in Maternal-Infant Care. His research focuses on improving quality of care, patient outcomes and health care services delivery.
He has received many awards for his work, including the Knowledge Translation Award from the Canadian Institutes of Health Research, the Aventis Pasteur Research Award and the Distinguished Neonatologist Award from the Canadian Paediatric Society, and the Premier Member of Honour Award from the Sociedad Iberoamericana de Neonatologia.
Presentation Abstract:
Hypoxic ischaemic encephalopathy (HIE) is a manifestation of disordered neonatal brain function resulting from a recent hypoxic ischaemic episode, usually occurring during labor and delivery. It is a common event, with a reported incidence of 1-8/1000 live births and appears to be more prevalent in developing countries than in developed ones. In this lecture, we will explore the epidemiology of hypoxic ischaemic encephalopathy, the pathogenesis and risk factors associated with it, the outcomes of neonates with the condition, and the cost implications of the condition. We will also examine how outcomes may change with new approaches to treatment and health care delivery.
^ Back to Top